Showing results (51-60 of 149) with videos related to

Sort By:
Pageof 15
Research Square|March 30, 2023
The Impact of Race and Age on Response to Neoadjuvant Therapy and Long-Term Outcomes in Black and White Women with Early-Stage Breast CancerElizabeth Terman, Jori Sheade, Fangyuan Zhao, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2024
Retrospective evaluation of adjuvant capecitabine dosing patterns in triple negative breast cancerKun Lin, Elena Michaels, Eric Polley, et al.
Breast Cancer Research and Treatment|September 5, 2022
Highly accurate response prediction in high-risk early breast cancer patients using a biophysical simulation platformFrederick M Howard, Gong He, Joseph R Peterson, et al.
Cancer Research|December 3, 2005
BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomyMinjie Wei, Tatyana A Grushko, James Dignam, et al.
Breast Cancer Research and Treatment|July 29, 2017
Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centersCesar A Santa-Maria, Megan Kruse, Paola Raska, et al.
Academic Radiology|March 30, 2022
Differences Between Ipsilateral and Contralateral Early Parenchymal Enhancement Kinetics Predict Response of Breast Cancer to Neoadjuvant TherapyZhen Ren, Federico D Pineda, Frederick M Howard, et al.
JAMA|October 20, 2005
Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestryRita Nanda, L Philip Schumm, Shelly Cummings, et al.
Breast Cancer (Dove Medical Press)|April 20, 2026
Single-Cell Profiling Reveals a Treg-Rich, NK Cell-Depleted Immune Microenvironment in Triple-Negative Breast Cancer with High-Glucocorticoid Receptor ExpressionJoshua Behar, Christine Shiang, Deniz Nesli Dolcen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2016
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 StudyRita Nanda, Laura Q M Chow, E Claire Dees, et al.
Oncotarget|May 26, 2016
Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patientsGladys Morrison, Divya Lenkala, Bonnie LaCroix, et al.
Pageof 15